Our work was based on a previous study [14] involving a different group of patients in whom we observed that, in lymphomas, it was feasible to identify the presence of exosomes in blood, and that unfavorable markers in plasma, mainly C-MYC mRNA, were associated with poor prognosis in B-cell lymphomas,. This evidence concerns the gene MYC and lymphoma.